Sanofi

Sanofi/Genzyme CVRs plunge 40%
Marketwatch
Thu, 07/28/11 - 12:20 pm
Sanofi
Genzyme
CVRs
Sanofi-Aventis 2nd quarter earnings drop
Yahoo/AP
Thu, 07/28/11 - 09:32 am
earnings
Sanofi
Sanofi Is Conducting ‘Deeper’ Strategic Review of Merial
Bloomberg
Thu, 07/28/11 - 09:32 am
animal health
Merial
Sanofi
Pfizer
Four Drug Stocks To Watch On Thursday
Investopedia
Wed, 07/27/11 - 01:21 pm
Celgene
Bristol-Myers Squibb
United Therapeutics
Sanofi
Key blockbuster drugs about to get generic rivals
Yahoo/AP
Mon, 07/25/11 - 09:10 am
generics
Eli Lilly
Forest Labs
Pfizer
AstraZeneca
Cephalon
Bristol-Myers Squibb
Sanofi
patents
Abbott Laboratories
Merck
Takeda
Novartis
Endo
GSK
AstraZeneca Wins U.S. Approval for Blood Thinner Brilinta to Rival Plavix
Bloomberg
Wed, 07/20/11 - 06:46 pm
Plavix
blood thinners
AstraZeneca
Sanofi
Bristol-Myers Squibb
Brilinta
Dawn of A New Sleep Drug?
WSJ Online
Tue, 07/19/11 - 11:54 am
insomnia
GSK
Actelion
Sanofi
3 Dividend Paying Pharma Stocks That Will Profit Off of Rising Obesity Rate
Seeking Alpha
Sun, 07/17/11 - 12:06 pm
Novo Nordisk
Eli Lilly
Sanofi
obesity
Sanofi's Multaq under EU Review
Yahoo/Zacks
Sat, 07/16/11 - 11:53 am
Sanofi
Multaq
High Yield Large-Cap Pharma: Recent Performance and 5-Year Dividend Growth Analysis
Seeking Alpha
Sat, 07/16/11 - 11:45 am
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
GSK
Merck
Pfizer
Sanofi
Unilife Supplies Unifill to Sanofi
Thu, 07/14/11 - 01:23 pm
Unilife
supply
Sanofi
Phase III Data Mixed on Sanofi's Lemtrada
Yahoo/Zacks.com
Wed, 07/13/11 - 06:25 pm
Sanofi
Lemtrada
MS
multiple sclerosis
alemtuzumab
Sanofi and Regeneron Report Positive Phase 2b Trial Results with Sarilumab in Rheumatoid Arthritis
Yahoo
Wed, 07/13/11 - 08:29 am
Regeneron
Sanofi
Sarilumab
rheumatoid arthritis
ankylosing spondylitis
Sanofi-Genzyme MS Drug: Mixed Results
TheStreet.com
Mon, 07/11/11 - 09:50 am
MS
multiple sclerosis
Sanofi
Genzyme
Regeneron's VENICE Study to Continue
Yahoo/Zacks
Sat, 07/9/11 - 10:58 am
Regeneron
Zaltrap
prostate cancer
Sanofi
Sanofi stops Multaq study due to safety concerns
Marketwatch
Thu, 07/7/11 - 11:18 am
Sanofi
Multaq
Eli Lilly Reaffirms Commitment to Innovation but Needs to Deliver
Seeking Alpha
Tue, 07/5/11 - 04:37 pm
innovation
Eli Lilly
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
GSK
JNJ
Merck
Novartis
Pfizer
Roche
Sanofi
New Data on Abbott Kidney Drug Candidate
Yahoo/Zacks.com
Tue, 06/28/11 - 11:35 pm
Abbott Laboratories
Shire
Sanofi
bardoxolone methyl
Reata
kidney disease
Shire to Produce More Replagal
Yahoo/Zacks.com
Tue, 06/28/11 - 08:41 am
Shire
Replagal
Sanofi
Fabry's disease
AstraZeneca’s Brilinta Worse With High-Dose Aspirin Doses in Analysis
Bloomberg
Mon, 06/27/11 - 05:53 pm
Brilinta
AstraZeneca
aspirin
Plavix
Sanofi
Bristol-Myers Squibb

Pages